NCT00172302

Brief Summary

Intravenous vitamin C may improve skin hyperpigmentation in chronic hemodialysis patients

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 15, 2005

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2005

Completed
Last Updated

September 15, 2005

Status Verified

May 1, 2005

First QC Date

September 12, 2005

Last Update Submit

September 12, 2005

Conditions

Kidney Failure, Chronic

Outcome Measures

Primary Outcomes (1)

  • Skin pigmentation extent

Secondary Outcomes (1)

  • blood anti-oxidant level

Interventions

vitamin C, intravenous injectionDRUG

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic hemodialysis patients

You may not qualify if:

  • allergic to vitamin C, using steroid, etc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Ascorbic AcidInjections, Intravenous

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydratesAdministration, IntravenousDrug Administration RoutesDrug TherapyTherapeuticsInjections

Study Officials

  • Kao Tze-Wah, MD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 15, 2005

Study Start

November 1, 2005

Last Updated

September 15, 2005

Record last verified: 2005-05

Locations

TW(1)